Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1993 Jul;79(3):439–444.

CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.

J Kwekkeboom 1, M De Boer 1, J M Tager 1, C De Groot 1
PMCID: PMC1421996  PMID: 7691726

Abstract

A mutant subclone of the murine thymoma EL-4, known as EL4B5, can strongly activate human B cells to proliferate and differentiate in a cell-cell contact-dependent manner. We have investigated whether interaction via CD40 plays a role in this helper activity. For this purpose, three newly generated anti-CD40 monoclonal antibodies (mAb) were used. In contrast with other anti-CD40 mAb described in the literature, these mAb did not co-stimulate proliferation of human B cells. On the other hand, these novel mAb could inhibit the co-stimulatory effect of the previously described anti-CD40 mAb S2C6 on anti-IgM-induced human B-cell proliferation. It was found that addition of these non-stimulatory anti-CD40 mAb could completely inhibit EL4B5-induced human B-cell proliferation. Maximal inhibition occurred already at a mAb concentration of 10 ng/ml. Similarly, a fusion protein, consisting of the extracellular portion of CD40 and human IgM constant domains CH2, CH3 and CH4, could completely inhibit EL4B5-induced human B-cell proliferation. Induction of human B-cell proliferation by EL4B5 cells was also inhibited by anti-CD40 mAb S2C6 and G28.5, but less effectively. In contrast, mAb against B-cell surface antigens CD20 or B7 had no inhibitory effects. It is concluded that interaction via CD40 is essential for the induction of human B-cell proliferation by EL4B5 cells.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R. Molecular and biological characterization of a murine ligand for CD40. Nature. 1992 May 7;357(6373):80–82. doi: 10.1038/357080a0. [DOI] [PubMed] [Google Scholar]
  2. Banchereau J., de Paoli P., Vallé A., Garcia E., Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 1991 Jan 4;251(4989):70–72. doi: 10.1126/science.1702555. [DOI] [PubMed] [Google Scholar]
  3. Barneveld R. A., Tegelaers F. P., Ginns E. I., Visser P., Laanen E. A., Brady R. O., Galjaard H., Barranger J. A., Reuser A. J., Tager J. M. Monoclonal antibodies against human beta-glucocerebrosidase. Eur J Biochem. 1983 Aug 15;134(3):585–589. doi: 10.1111/j.1432-1033.1983.tb07606.x. [DOI] [PubMed] [Google Scholar]
  4. Clark E. A., Ledbetter J. A. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4494–4498. doi: 10.1073/pnas.83.12.4494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. De Groot C., Braun J., Mevissen M. L., Wormmeester J. Contrasting effects of interleukin 4 (IL-4) on the in vitro proliferation of human B cells is due to the presence of B cell subsets in different activation states. Lymphokine Res. 1990 Fall;9(3):321–332. [PubMed] [Google Scholar]
  6. Gascan H., Gauchat J. F., Aversa G., Van Vlasselaer P., de Vries J. E. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J Immunol. 1991 Jul 1;147(1):8–13. [PubMed] [Google Scholar]
  7. Kwekkeboom J., van Oosten M., de Boer M., van Alphen L., Mevissen M. L., Lindhout E., Tager J. M., de Groot C. An efficient procedure for the generation of human monoclonal antibodies based on activation of human B lymphocytes by a murine thymoma cell line. J Immunol Methods. 1993 Mar 15;160(1):117–127. doi: 10.1016/0022-1759(93)90015-y. [DOI] [PubMed] [Google Scholar]
  8. Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 1992 Oct;22(10):2573–2578. doi: 10.1002/eji.1830221016. [DOI] [PubMed] [Google Scholar]
  9. Noelle R. J., Roy M., Shepherd D. M., Stamenkovic I., Ledbetter J. A., Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6550–6554. doi: 10.1073/pnas.89.14.6550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Paulie S., Rosén A., Ehlin-Henriksson B., Braesch-Andersen S., Jakobson E., Koho H., Perlmann P. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol. 1989 Jan 15;142(2):590–595. [PubMed] [Google Scholar]
  11. Vallé A., Zuber C. E., Defrance T., Djossou O., De Rie M., Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol. 1989 Aug;19(8):1463–1467. doi: 10.1002/eji.1830190818. [DOI] [PubMed] [Google Scholar]
  12. Warmerdam P. A., van de Winkel J. G., Vlug A., Westerdaal N. A., Capel P. J. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol. 1991 Aug 15;147(4):1338–1343. [PubMed] [Google Scholar]
  13. Wen L., Hanvanich M., Werner-Favre C., Brouwers N., Perrin L. H., Zubler R. H. Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies. Eur J Immunol. 1987 Jun;17(6):887–892. doi: 10.1002/eji.1830170624. [DOI] [PubMed] [Google Scholar]
  14. Zhang X. H., Hauser C., Zubler R. H. Soluble factor-independent stimulation of human B cell response by mouse thymoma cells. Cyclosporine A-resistant and -sensitive cell contact signals. J Immunol. 1990 Apr 15;144(8):2955–2960. [PubMed] [Google Scholar]
  15. Zubler R. H., Erard F., Lees R. K., Van Laer M., Mingari C., Moretta L., MacDonald H. R. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol. 1985 Jun;134(6):3662–3668. [PubMed] [Google Scholar]
  16. Zubler R. H., Werner-Favre C., Wen L., Sekita K., Straub C. Theoretical and practical aspects of B-cell activation: murine and human systems. Immunol Rev. 1987 Oct;99:281–299. doi: 10.1111/j.1600-065x.1987.tb01181.x. [DOI] [PubMed] [Google Scholar]
  17. de Boer M., Conroy L., Min H. Y., Kwekkeboom J. Generation of monoclonal antibodies to human lymphocyte cell surface antigens using insect cells expressing recombinant proteins. J Immunol Methods. 1992 Jul 31;152(1):15–23. doi: 10.1016/0022-1759(92)90084-7. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES